Inocras
Curated by SignalAI-driven platform provides whole genome insights for cancer and rare diseases
Overview
AI-driven platform provides whole genome insights for cancer and rare diseases. It has developed an IP-protected technology and proprietary whole genome insight platform to improve patient diagnosis and treatment by unlocking the full potential of genomic data.
Key facts
- Founded
- 2020
- Headquarters
- San Diego, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Business model
- 4 products and services
- Sign up to view
- Commercial model
- Sign up to view
Contact
- Sign up to view
- Phone
- Sign up to view